HBV/HDV Roundtable: HBV and HDV drug development - Where do we stand and where are we going?

This is the audio version of an episode that was originally broadcast live from The International Liver Congress 2022.

Prof. Pietro Lampertico (Moderator), Prof. Sabela Lens (Moderator), Dr John Flaherty (Faculty), Dr Melanie Paff (Faculty), Dr Gastón R. Picchio (Faculty), Prof. Mala Maini (Faculty)

This EASL Studio is supported by Arbutus Biopharma, Gilead Sciences, and GSK.

Listen to the podcast

Log in to post comments